Page last updated: 2024-11-11

methyl retinoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl retinoate: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5378821
CHEMBL ID488005
SCHEMBL ID990601
MeSH IDM0086535

Synonyms (30)

Synonym
ro 4-3781
beta-retinoic acid methyl ester
vitamin a acid methyl ester
all-trans-methylretinoate
vitamin a-saeuremethylester [german]
brn 2059353
methyl retinoate
retinoic acid, methyl ester, all-trans-
retinoic acid, methyl ester
CHEMBL488005
retinoic acid methyl ester
all-trans-retinoic acid methyl ester
retinoic acid, methyl ester, 13-cis-
methyl (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
ws76i7l4s7 ,
unii-ws76i7l4s7
339-16-2
vitamin a-saeuremethylester
all-trans retinoic acid methyl ester
SCHEMBL990601
all-trans-vitamin a acid methyl ester
SREQLAJQLXPNMC-DXYSAURFSA-N
.beta.-retinoic acid methyl ester
all-trans-methyl retinoate
861043-70-1
methyl all-trans-retinoate
J-019374
11-cis retinoic acid methyl ester
Q27292800
DTXSID401316812
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1136170Reversal of keratinized lesions in vitamin A deficient hamster tracheal organ culture assessed as cultures with keratin and keratohyaline granules at 10 nM after 7 days (Rvb = 93%)1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Dihydroretinoic acids and their derivatives. Synthesis and biological activity.
AID1136169Reversal of keratinized lesions in vitamin A deficient hamster tracheal organ culture assessed as cultures with keratin and keratohyaline granules at 0.1 uM after 7 days (Rvb = 93%)1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Dihydroretinoic acids and their derivatives. Synthesis and biological activity.
AID334311Induction of morphological transformation of rat ASK cells into astrocytes after 1 hr by light microscopy
AID1136173Increase in RNA content in mouse epidermal cells at 1 uM after 3 days1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Dihydroretinoic acids and their derivatives. Synthesis and biological activity.
AID1136176Increase in RNA content in mouse epidermal cells at 1 nM after 3 days1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Dihydroretinoic acids and their derivatives. Synthesis and biological activity.
AID1136174Increase in RNA content in mouse epidermal cells at 0.1 uM after 3 days1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Dihydroretinoic acids and their derivatives. Synthesis and biological activity.
AID1136175Increase in RNA content in mouse epidermal cells at 10 nM after 3 days1977Journal of medicinal chemistry, Jul, Volume: 20, Issue:7
Dihydroretinoic acids and their derivatives. Synthesis and biological activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (80.00)18.7374
1990's2 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.67 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]